Find uplifting stories about heroes, innovations, and solutions
3045 results for "hpv cancer"
Former hospital leader Kirk Thomas battled HPV-related throat cancer and nearly lost the ability to swallow. Now cancer-free for five years, he's helping others face their own diagnoses with courage.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
A groundbreaking study of 1.7 million Americans reveals that HPV vaccination slashes head and neck cancer rates by more than half in men. As smoking declines but these cancers rise, scientists have found the solution hiding in plain sight.
For the first time ever, zero women in their early 20s died from cervical cancer in England over a four-year period. Scientists credit the HPV vaccine with reducing cervical cancer death risk before age 30 to "effectively zero."
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
Young women vaccinated against HPV at age 12-13 now have close to zero risk of dying from cervical cancer before 30. A landmark study from England shows the vaccine has already saved around 200 lives since 2008.
For the first time ever, zero women aged 20-24 died from cervical cancer in the UK over a five-year period, thanks to routine HPV vaccination. Without the vaccine, 23 deaths would have been expected during that time.
Young women who get the HPV vaccine in their early teens have virtually no risk of dying from cervical cancer before age 30. This groundbreaking research proves the vaccine is even more life-saving than scientists initially believed.
A groundbreaking cancer vaccine has nearly eliminated cervical cancer in young women, with doctors reporting they rarely see the disease in patients under 25 anymore. The success story reveals how vaccines can prevent cancer and save lives.
After surviving cervical cancer through expensive treatment abroad, Irakoze Gratia celebrates as Burundi launches free HPV vaccines for girls. The preventable disease kills over 1,000 Burundian women each year.
For the first time ever, no women aged 20 to 24 died from cervical cancer in England over a five-year period. The HPV vaccine given to schoolgirls since 2008 has saved around 200 lives and given vaccinated children "close to zero" risk of dying from the disease before age 30.
Breakthrough vaccines and treatments are dramatically reducing HPV-related cancers that affect millions worldwide. Scientists now have powerful new tools to prevent and treat cervical, throat, and other cancers caused by the virus.
Cervical cancer is one of the most preventable cancers, yet it claims thousands of lives each year. A safe, proven vaccine could change that story completely.
Nigeria is embedding the HPV vaccine into routine school health programs to prevent cervical cancer, one of the most preventable yet deadliest cancers for women. Early efforts show promise, but scaling up could save thousands of lives.
The American Cancer Society now endorses self-collected HPV tests for cervical cancer screening, removing barriers that kept many women from accessing this lifesaving care. For people who face obstacles with traditional clinic visits, this change means finally getting screened.
For the first time in history, cervical cancer deaths fell to zero among women aged 20-24 in England. The breakthrough proves we can actually prevent cancer through vaccination.
Scientists in Mexico have successfully eliminated the virus that causes cervical cancer in patients using a groundbreaking light-based treatment. The therapy could offer new hope to millions of women worldwide who currently have limited options after HPV infection.
Kenya is launching new action plans to eliminate cervical cancer deaths, drawing inspiration from England's HPV vaccine success. With fresh funding and partnerships, the country aims to reach every woman and girl with preventive care.
Scientists have developed a therapeutic vaccine that successfully fought HPV-related cancers in mice, offering hope for patients with advanced disease. Unlike current vaccines that only prevent infection, this treatment targets existing tumors.
Showing 20 of 3045